Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE010 (ESP) (Dr. Silva)
· consented 2022-04-07
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Pruritus — outcome: RECOVERED/RESOLVED; onset 2022-05-21 (study day 29); relationship: Y
moderate
assessed
2026-08-18
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-06-01 (study day 40); relationship: Y
mild
assessed
2026-08-18
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-17 (study day 209); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-12-10 (study day 232); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.